[Use of phytohemagglutinins in oncology].
D000036:Abrin / Q000494:pharmacology; D000371:Agglutination / Q000187:drug effects; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology; D001665:Binding Sites; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002478:Cells, Cultured; D003208:Concanavalin A / Q000494:pharmacology; D006023:Glycoproteins / Q000276:immunology; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D066298:In Vitro Techniques; D037102:Lectins / Q000494:pharmacology*; D007945:Leukemia, Lymphoid / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology*; D011955:Receptors, Drug / Q000187:drug effects; D012276:Ricin / Q000494:pharmacology
D000970:Antineoplastic Agents; D006023:Glycoproteins; D037102:Lectins; D011955:Receptors, Drug; D003208:Concanavalin A; D000036:Abrin; D012276:Ricin
Primenenie fitogemaggliutininov v onkologii